View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Respiratory Infections News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 21, 2022
1 min read
Save

IDSA announces courage award honoring Fauci

IDSA announces courage award honoring Fauci

The Infectious Diseases Society of America on Friday announced the creation of an award honoring National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci, MD.

SPONSORED CONTENT
October 21, 2022
1 min read
Save

What will be the most significant consequence of long COVID?

What will be the most significant consequence of long COVID?

Long COVID can cause multisystem health issues that can last anywhere from months to years. We asked Farha S. Ikramuddin, MD, MPH, assistant professor in the department of rehabilitation medicine at the University of Minnesota Medical School, what the most significant consequence of long COVID will be moving forward.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
October 21, 2022
1 min read
Save

Hooked on ID with David Boulware, MD, MPH

Hooked on ID with David Boulware, MD, MPH

I grew up in a household surrounded by medicine and the medical needs of my sister. It was an environment I had become accustomed to and later became the focal point of my studies.

SPONSORED CONTENT
October 21, 2022
2 min watch
Save

VIDEO: Incoming IDSA President Carlos del Rio, MD, lays out agenda for next year

VIDEO: Incoming IDSA President Carlos del Rio, MD, lays out agenda for next year

WASHINGTON — Carlos del Rio, MD, an Infectious Disease News Editorial Board Member and the new president of the Infectious Diseases Society of America, discussed his agenda with Healio.

SPONSORED CONTENT
October 20, 2022
3 min read
Save

Multiple RSV vaccines in late-stage development show promise in older adults

Multiple RSV vaccines in late-stage development show promise in older adults

WASHINGTON — Three late-breaking studies offered a promising glimpse of respiratory syncytial virus vaccines in the pipeline for older adults — including the RSVPreF3 OA vaccine, which showed an overall vaccine efficacy of about 83%.

SPONSORED CONTENT
October 20, 2022
2 min read
Save

US gives nod to Novavax’s COVID-19 booster as alternative to mRNA shots

US gives nod to Novavax’s COVID-19 booster as alternative to mRNA shots

The FDA authorized a booster shot of Novavax’s COVID-19 vaccine, giving the United States an option for people who cannot or will not receive a messenger RNA vaccine.

SPONSORED CONTENT
October 18, 2022
1 min read
Save

Disease outbreaks linked to adverse mental health issues in adolescents, young people

Disease outbreaks linked to adverse mental health issues in adolescents, young people

The COVID-19 pandemic and H1N1 epidemic were associated with adverse mental health events in adolescents and youth from low- and middle-income countries, researchers reported in JAMA Psychiatry.

SPONSORED CONTENT
October 14, 2022
2 min read
Save

COVID-19 rebound not due to impaired immune response, small study suggests

COVID-19 rebound not due to impaired immune response, small study suggests

COVID-19 rebound in people who have recovered from the disease is not due to an impaired immune response, according to a small study of patients treated with and without Paxlovid.

SPONSORED CONTENT
October 14, 2022
2 min read
Save

People with HIV should participate in tuberculosis vaccine trials, new recommendations say

People with HIV should participate in tuberculosis vaccine trials, new recommendations say

Experts say that people with HIV should be included in clinical trials for new tuberculosis vaccine candidates in the pipeline, according to newly written recommendations published in The Lancet HIV.

SPONSORED CONTENT
October 13, 2022
2 min read
Save

Early data show Pfizer’s omicron booster ‘substantially’ boosted antibodies against BA.5

Early data show Pfizer’s omicron booster ‘substantially’ boosted antibodies against BA.5

Early data from trials assessing the new Pfizer and BioNTech omicron-adapted booster vaccine show that the vaccine substantially increased protective antibodies against the BA.5 subvariant in adults.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails